Trials / Completed
CompletedNCT05783830
Study Evaluating the Pharmacokinetics of a Single Microdose of ACD856
A Phase 0, Open-label, Non-controlled Study to Evaluate the Pharmacokinetics of a Single Intravenous Microdose of ACD856 in Healthy Volunteers
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- AlzeCure Pharma · Industry
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This is a Phase 0, open-label, non-controlled, single-centre study designed to evaluate the pharmacokinetics (PK) and safety and tolerability of a single, bolus intravenous (iv) injection of a microdose of ACD856 in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ACD856 | IV injection 100 mcg |
Timeline
- Start date
- 2020-01-13
- Primary completion
- 2020-04-18
- Completion
- 2020-04-18
- First posted
- 2023-03-24
- Last updated
- 2023-03-24
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT05783830. Inclusion in this directory is not an endorsement.